Exelixis, Inc. (NASDAQ:EXEL) was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.29 to $5.19 in the past one-month time frame.
The company witnessed one positive estimate revision over the past 7 days. The Zacks Consensus Estimate, however, remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Exelixis currently has a Zacks Rank #3 (Hold).
A better-ranked stock in the Med-Biomed/Gene industry is Adaptimmune Therapeutics plc (NASDAQ:ADAP) , which sports a Zacks Rank #1 (Strong Buy).
Is EXEL going up? Or down? Predict to see what others think: Up or Down
EXELIXIS INC (EXEL): Free Stock Analysis Report
ADAPTIMMUNE THR (ADAP): Free Stock Analysis Report
Original post